Latest Breaking News On - Neurocrine biosciences - Page 10 : vimarsana.com

FDA Approves New Ingrezza Formulation for Patients Who Have Difficulty Swallowing

Each Ingrezza Sprinkle capsule contains oral granules consisting of valbenazine, a vesicular monoamine transporter 2 inhibitor.

Neurocrine-biosciences
Eiryw-roberts
Drug-administration
Ingrezza-sprinkle
Chief-medical-officer

Neurocrine Stock Pops After Ingrezza Snatches Another Quarterly Win

Neurocrine Stock Pops After Ingrezza Snatches Another Quarterly Win
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine-biosciences
Composite-rating
Relative-strength-rating

Neurocrine Stock Pops After Landing A Key Regulatory Filing | Investor's Business Daily

Neurocrine Stock Pops After Landing A Key Regulatory Filing | Investor's Business Daily
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Laura-chico
Brian-abrahams
Neurocrine-biosciences
Industry-group-ranking
Drug-administration
The-day
Wall-street
Ingrezza-beats-most
Takeda-pharmaceutical
Composite-rating
Relative-strength-rating

NBIX Stock Earnings: Neurocrine Biosciences Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips NBIX stock results show that Neurocrine Biosciences beat analyst estimates for earnings per…

Neurocrine-biosciences
Market-news
Stock-advice
Neurocrine-biosciences-beats
Beats-revenue
News
Ggregator
Reaking-news
Uration
Edia

New E. Coli Outbreak; How ECMO Redefines Death; A Step Closer to Universal Blood

Health news and commentary gathered by <em>MedPage Today</em> staff

China
Chicago
Illinois
United-states
New-york
New-yorker
Chinese
Zhang-yongzhen
Kate-middleton
Neurocrine-biosciences
World-health-organization
Johnson

Neurocrine bags FDA approval for new 'sprinkle' Ingrezza formulation

The sprinkle formulation of Ingrezza is approved as an alternative for Huntington’s patients who have difficulty swallowing.

Neurocrine-bioscience-huntington
Takeda-pharmaceuticals
Drug-administration
Ingrezza-sprinkle
Depression-rating-scale
Pharmaceutical-technology
Neurocrine-biosciences
Ood-and-drug-administration
Huntingtons-disease
Tardive-dyskinesia
Ingrezza
Pharmaceutical-technology

Needham & Company LLC Reiterates "Hold" Rating for Neurocrine Biosciences (NASDAQ:NBIX)

Needham & Company LLC Reiterates "Hold" Rating for Neurocrine Biosciences (NASDAQ:NBIX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Neurocrine-biosciences
Ingrid-delaet
Eric-benevich
Securities-exchange-commission
Benjaminf-edwards-company-inc
Mather-group
Needham-company
Neurocrine-biosciences-inc
Edgerock-capital
Goldman-sachs-group
Lindbrook-capital

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine-biosciences
Alpine-immune-sciences
Relative-strength
Halozyme-therapeutics
Pharmaceutical-industry-and-stock-news

Neurocrine Stock Pops After Landing A Key Regulatory Filing | Investor's Business Daily

Neurocrine Stock Pops After Landing A Key Regulatory Filing | Investor's Business Daily
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine-biosciences
Brian-abrahams
Laura-chico
Industry-group-ranking
Drug-administration
The-day
Wall-street
Ingrezza-beats-most
Takeda-pharmaceutical
Composite-rating
Relative-strength-rating

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information .

San-diego
California
United-states
San-francisco
London
City-of
United-kingdom
San-bernardino
University-of-california-irvine
Buckinghamshire
Cambridge
Cambridgeshire